The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2026

Filed:

Dec. 13, 2021
Applicant:

Societe Des Produits Nestle S.a., Vevey, CH;

Inventors:

Albert Giralt, Lausanne, CH;

Marine Kraus, Vuarrens, CH;

Philipp Gut, Geneva, CH;

Giulia Lizzo, Echandens, CH;

Gabriele Civiletto, Lausanne, CH;

Leonidas Georgios Karagounis, Vaud, CH;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 31/05 (2006.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/05 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01);
Abstract

The present disclosure generally relates to compositions and methods that can treat or prevent nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis and/or hepatic steatosis (fatty liver). More specifically, the present disclosure relates to administering a formulation comprising a combination of at least one glycine or functional derivative thereof, and/or at least one N-acetylcysteine or functional derivative thereof, and at least one thymol and/or carvacrol, in an amount effective to decrease liver steatosis. The formulation can concomitantly decrease liver damages, in particular those observed in patients with NAFLD.


Find Patent Forward Citations

Loading…